A New Interpretation of the Drug Levodopa in the Treatment of Parkinson\u27s Disease by Vannah, Joanne T.
University of Massachusetts Boston
ScholarWorks at UMass Boston
Graduate Masters Theses Doctoral Dissertations and Masters Theses
6-2005
A New Interpretation of the Drug Levodopa in the
Treatment of Parkinson's Disease
Joanne T. Vannah
University of Massachusetts Boston
Follow this and additional works at: http://scholarworks.umb.edu/masters_theses
Part of the Biotechnology Commons, Diseases Commons, Neuroscience and Neurobiology
Commons, and the Neurosciences Commons
This Open Access Thesis is brought to you for free and open access by the Doctoral Dissertations and Masters Theses at ScholarWorks at UMass
Boston. It has been accepted for inclusion in Graduate Masters Theses by an authorized administrator of ScholarWorks at UMass Boston. For more
information, please contact library.uasc@umb.edu.
Recommended Citation
Vannah, Joanne T., "A New Interpretation of the Drug Levodopa in the Treatment of Parkinson's Disease" (2005). Graduate Masters
Theses. Paper 178.
A NEW INTERPRETATION OF THE DRUG LEVODOPA IN 
THE TREATMENT OF PARKINSON'S DISEASE 
A Thesis Presented 
by 
Joanne T. Vannah 
Submitted to the Office of Graduate Studies, 
University of Massachusetts Boston, in partial fulfillment of the requirements for 
the degree of 
MASTER OF SCIENCE 
June 2005 
Biotechnology Program 
©2005 by Joanne T. Vannah 
All rights reserved 
A NEW INTERPRETATION OF THE DRUG LEVODOPA IN 
THE TREATMENT OF PARKINSON'S DISEASE 
A Thesis Presented 
by 
Joanne T. Vannah 
Approved as to style and content by: 
Kelfneth L. Campbell, 'l'FOressof 
Robert Stevenson, Associate Professor 
Member 
Greg Beck, Program Director 
Biotechnology Program 
Manickam Sugumaran, Chairperson 
Biology Department 
ABSTRACT 
A NEW INTERPRETATION OF THE DRUG LEVODOPA IN 
An 
THE TREATMENT OF PARKINSON'S DISEASE 
June 2005 
T. Vannah, B.A., Boston University 
B.S., University of Massachusetts Boston 
M.S., University of Massachusetts Boston 
Directed by Professor Alexia Pollack 
striatal LTD is lost following DA denervation and chronic levodopa treatment. It is 
possible that 
achetylcholine (ACh) and glutamate, which in tum leads to the induction of striatal LTP. 
ACh and glutamate may produce these in motor behavior by affecting the 
striosomal pathway in addition to their on the direct (striatonigral) pathway and the 
indirect (striatopallidal) pathway of the basal ganglia. This thesis postulates that by 
blocking LTP expression in the DA depleted striatum, that the occurrence of LID will be 
reduced. Heterosynaptic plasticity is a mechanism in which long-tem1 facilitation 
proceeds in the state of LTD or L TP depending on the levels of intracellular calcium 
IV 
present Artificial neural networks (ANN) may be used to speculate and predict the most 
accurate and precise combinations of levodopa, ACh antagonist and glutamate 
antagonists that will achieve the goal of preventing L TP in DA denervated and chronic 
levodopa treated biological systems to reduce/eliminate LID. 
v 
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CHAPTER 1 
INTRODUCTION 
Parkinson's disease (PD) is a movement disorder that affects more than half a 
million people in the United States (Langer A and Lozano R, 1998). Individuals with PD 
experience motor abnormalities as a result of this neurodegenerative disease (Langer A 
and Lozano R, 1998). Early motor disturbances are presented as tremors usually in one of 
the extremities. As the disease progresses over time, additional motor complications 
appear. These motor complications include patients becoming stiff and their actions 
become delayed. Some PD patients begin to have trouble initiating movements, losing 
coordination or complete lack of mobility. Non-motor symptoms associated with PD such 
as mood, sleep and cognitive disturbances are also prevalent but will not be discussed in 
paper (Langer A and Lozano R, 1998). The typical onset of PD occurs in patients 
between the of 50-60 (]ellinger 2001). Because some of the initial motor 
disturbances are subtle, the diagnosis may not be immediately recognized. As the 
neurodegenerative progression builds steadily, PD symptoms become obvious and very 
confining for patients who 
(Klawans HL, 1996). 
lived with the disease for an often years 
The primary brain regions affected in PD are the basal ganglia (Pollack AE, 
2001 ). A substantial decrease in the neurotransmitter, dopamine (DA), as is the case in 
PD has dramatic effects on the basal ganglia. As a result, the symptoms ofPD are 
treatable by pharmaceutical agents (Langer A and Lozano R, 1998). The most commonly 
used drug treatment for PD is DA replacement therapy with the most effective drug being 
1 
levodopa, the chemical precursor to DA (CaJon F. eta!., 2000). Levodopa is absorbed in 
the gastrointestinal tract in the small bowel and is rapidly distributed to other tissues with 
a half-life of 5-10 minutes (Koller WC, 2000). Levodopa readily crosses the blood brain 
barrier whereas exogenously administered DA itself is unable to do so. Although initially 
effective, chronic treatment with levodopa results in debilitating side effects such as the 
uncontrollable, involuntary movements known as dyskinesias (CaJon F. et al., 2000; 
Hirsch E., 2001). 
The purpose of this thesis is to present a new hypothesis for the mechanism 
underlying levodopa induced dykinesias (LID), which posits that these abnormal, 
involuntary movements are the result of disturbances of a memory mechanism in the 
basal ganglia that promotes long term changes ultimately leading to LID. Because the 
neurotransmitters in the basal ganglia involved in LID and their interactions with one 
another arc not clearly defined, an artific1al neural network (ANN) model will be 
presented as an appropriate method for assessing these neurotransmitter relationships. 
Once developed, the ANN can be trained to prevent these long-term memory changes 
from occurring within the model system, thereby potentially uncovering therapeutic 
regiments to control LID. In order to understand this hypothesis, an overview of the 
anatomy and physiology of the basal ganglia, the brain regions involved in PD, is 
presented. This anatomical insight provides a foundation for understanding the cellular 
mechanisms in the basal ganglia that arc activated during LID. 
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Basal Ganglia Anatomy 
The basal ganglia consist of brain regions that serve as a key processing center in 
the control of movement as well as the processing of a certain types of motor memory 
associated with conditioned responses (Graybiel AM et al., 2000). The basal ganglia 
structures are compromised of five extensively interconnected subcortical nuclei in the 
forebrain that wrap around the thalamus beneath the anterior portion of the lateral 
ventricles (Graybiel AM, 1990). The individual structures are specifically termed: 
caudate nucleus, putamen, globus pallidus, subthalamic nucleus and substantia nigra 
(Figure 1) (Graybiel AM, 1990). The basal ganglia structures form an intricate network 
of parallel loops that integrate and redistribute information from the cortex, and in tum, 
project this information to the thalamus that affects the motor cortex in the frontal lobe 
(Smith D. et al., 1997). 
Information coming into the basal ganglia originates from a variety of locations in 
the cerebral cortex, thalamus and the limbic system (Parent A. et a!., 200 l ). This input 
enters the basal ganglia in the striatum (Parent A. et al., 2001 ), which is a collective term 
for the caudate and putamen (Parent A. ct al., 2001 ). Inputs to the striatum from the 
thalamus and cortex are excitatory and usc the neurotransmitter glutamate (Pollack AE, 
2001; Smith A. et al., 1998). Other inputs include serotonin from the Raphe nucleus, 
achctylcholine (ACh) from striatal intcmeurons and DA from the substantia nigra pars 
compacta (SNc) as described below (Pollack AE, 2001). 
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Figure 1: (inodifiedfrom MoussaBH and Riederer Youdim and Peter, 1997) Basal 
Ganglia Structures: caudate nucleus, putamen, glohus pallidus, suhthalamic nucleus and 
suhstantia nigra. The pars compacta of the suhstantia nigra loses dopamine neurons 
which disturhs motor control in PD. The suhstantia nigra DA neurons fo rm the 
nigrostriata/ pathway as they proJect to the striatum. The raphe nuclei which supplies 
serotonin to the hasal ganglia loses neurons that produces nonmotor disturhances (e.g. 
depression) in PD. 
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Once information has reached the striatum it is processed through the basal 
ganglia circuitry before exiting the thalamus and brainstem via the basal ganglia output 
structures: the globus pallidus (GPi) and the substantia nigra reticulata (SNr) (Starr MS, 
1995). The GP is divided into internal (GPi) and external (GPe) segments (Albin RL et 
a!., 1998). Similarly, the substantia nigra, which is located in the midbrain, has several 
components, the SNr and the SNc (Albin RL et al., 1998). The SNc contains the DA 
neurons that project to the striatum and form the nigrostriatal pathway (Smith A. et al., 
1997). It is the DA neurons of the SNc that degenerate in PD. 
Basal Ganglia Circuitty 
Between the basal ganglia inputs and outputs arc two major pathways of 
projection neurons whose cell bodies arc located in the stnatum (Smith A. ct al., 1997). 
These arc referred to as the "direct" and ''indirect" pathways. In the current model of 
basal ganglia function, all information conveyed through the basal ganglia input 
structures is processed withm the basal ganglia and flows out through one of these 
pathways to the basal ganglia output structures (Figure 2) (Smith A. eta!., 1997). The 
concerted and contrasting effects ofthc "direct" and "indirect" pathways function to 
control motor behavior in the basal ganglia by supplying both a break and an accelerator 
on the thalamus. 
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Figure 2: (modified from Pollack AE, 2001) Basal Ganglia Circuitry: Connections and 
Neurochemical Modulators: Glutamate (Glut:excitatOty) connections lead from the 
cortex to the striatum, from the STN to the SNr!GPi and from the thalamus to the cortex. 
All other connections are inhibitory and utilize gamma-aminohutyric acid (GABA; 
inhihitof}). 
All the connections within the basal ganglia are inhibitory with the exception of 
the projection from STN to SNr/GPi which is excitatory (Figure 2) (Gerfen CR et al., 
1990). The direct pathway consists of a direct inhibitory projection to the SNr/GPi which 
allows the inhibition directed to the thalamus from the SNr/GPi to be reduced (Smith A. 
et al., 1997). The indirect pathway has an excitatory connection to the GPi/SNr, the STN, 
thereby causing greater inhibition to the thalamus (Smith A. et al., 1997). As information 
passes through the basal ganglia and becomes modified, this information projects to three 
thalamic nuclei: the ventral lateral, the ventral anterior and the mediodorsal (Smith A. et 
al., 1997). These thalamic nuclei then projects to the prefrontal cortex, the premotor 
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cortex (PMC), the supplementary motor area (SMA) and the primary motor cortex (Smith 
A. et al., 1997). The SMA is a major input to the basal ganglia and therefore creates a 
loop between the SMA and the basal ganglia (Smith A. et al., 1997). The SMA is 
involved with planning sequences of movement (Smith A. et al., 1997). Without the 
thalamus receiving information from the basal ganglia and conveying this information 
back to the cortex, the cortex would not be able to properly direct voluntary motor control 
(Gerfen CR, 1990). This Cortico-Basal Ganglia-Loop is maintained by two 
neurotransmitters: glutamate (excitatory) and gamma-amino butyric acid (GABA) 
(iuhibitory) (Figure 3) (Rascol 0. et al., 2001). 
DA that is 
pathway through D 1 receptors and inhibitory ette~cts on the indirect pathway 
acting through D2 receptors (Rascol 0. et al., 2001). striatal projection neurons in 
direct and indirect comprise 90-95% of the neuronal populations of the 
striatum and are medium spiny neurons that contain the iuhibitory neurotransmitter 
GABA. The one connection in the basal from the STN to the SNr/GPi, 
uses glutamate as its excitatory neurotransmitter (Gerfen CR, 1990). Input from the 
cortex to the striatum is also excitatory and uses glutamate as its neurotransmitter ( Gerfen 
CR, 1990). 
Five different types ofDA receptors have been cloned (Parent A. et aL, 2001). Dl 
like receptors (D 1 and D5) stimulate intracellular adenosine 3 '5 '-eye lie phosphate 
(cAMP) production, whereas D2 like receptors (D2-D4) iuhibit cAMP production 
(Gerfen et at. 1990). Primarily Dl and D2 receptors are located on the shafts of dendritic 
spines of GABA containing striatal projection neurons (Pollack AE, 2001 ). 
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Figure 3: (modified from Carlson NR, 2001) The Cortico-Basal Ganglia Loop. The 
connections of the excitatory Dl receptor activity and inhibitory D2 receptor activity are 
shown. The cortico-basal ganglia motor loop, maintained by information about planned 
movements executed by the primary motor cortex (PMC) and the primary somatosensory 
cortex (PSC). Inputs from the PMC and PSC project to the putamen. The signal then 
proceeds to the caudate and globus pallidus and returns back to the motor cortex via the 
ventrolateral thalamus. The loop is completed when the information from the PMC and 
PSC are sent to the putamen. 
8 
Excitatory glutamatergic inputs synapse on the heads of these same dendritic spines 
(Pollack AE, 2001). It has been proposed that due to their close proximity and anatomical 
arrangement, that DA synaptic activity may modulate glutamatergic input on these 
medium spiny neurons (Pollack AE, 2001). 
Approximately 1-2% of the neuronal population in the striatum are the large , 
aspiny interneurons with extensive collaterals that use ACh as a neurotransmitter (Starr 
MS, 1995). Three different types of ACh muscarinic receptors are found in the striatum: 
M1, M2 aand M4 (Blanchet F. et al., 1997; Pollack AE, 2001). Ml and M4 muscarinic 
receptors are located on both cholinergic interneurons as well as on medium spiny 
neurons (Pollack AE, 2001). M2 muscarinic receptors are located on cholinergic 
interneurons as are 02 & D5 receptors and to a much smaller degree D 1 receptors 
(Blanchet F. et al., 1997; Pollack AE, 2001 ). ACh synapses have been found on the 
dendritic spines and cell bodies of medium spiny neurons (Pollack AE, 2001 ). These 
ACh interneurons, as well as medium spiny neurons, also express ionotropic glutamate 
receptors, N-methyl-D-aspartate (NMDA) receptors and Alpha-amino-3-hydroxy-5-
methyl-4-isoxazole-propionic acid (AMP A) receptors. 
Recent evidence suggests that muscarinic receptor activation has a role in 
stabilizing the physiological states of striatal neurons (Suzuki T. et al., 1998). Calabresi 
P. et al. (1999) described striatal neurons a having two physiological states denoted as 
"down" and "up." A "down" state describes a neuron that is hyperpolarized and an "up" 
state describes a depolarized striatal neuron (Calabresi P. et al., 1999). In this thesis, the 
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physiological states of striatal neurons will be referred to as hyperpolarized and 
depolarized. Normally, the striatal neurons show very little excitability due to the large 
number of potassium channels that oppose the influx of calcium (Nisenbaum ES et al., 
1996). Therefore, the typical state for a striatal neuron is hyperpolarized (Calabresi P. et 
al., 1999). Following DA denervation, there is a rise in the excitatory neurotransmitter 
glutamate in the striatum and striatal neurons spend less time in their hyperpolarized state 
and enter an oscillating state where the neurons frequently shift from a hyperpolarized 
state to a depolarized state (Calabresi P. et al., 1997). Since these oscillatory striatal states 
are unable to be reproduced in vitro this suggests that an intact corticostriatal system is 
necessary to induce this oscillatory behavior (Calabresi P. et al., 1990). NMDA and 
AMPA glutamate receptors located on medium spiny neurons are also differentially 
activated in the striatum depending upon which physiological state the striatal neurons 
are in (Calabresi P. et al, 1997). The striatal depolarized state is correlated with NMDA 
receptor activation, whereas the striatal hyperpolarized state is correlated with AMPA 
receptor activation (Calabresi P. et al., 1997). ACh has also been found to enhance the 
NMDA mediated responses recorded from medium spiny cells in the striatum (Guebellini 
et al., 1998), suggesting a possible role of ACh in inducing a long lasting elevation of 
corticostriatal glutamatergic transmission (Guebellini P. et al., 1998). The increase of 
ACh in the striatum, elevates NMDA receptor activation on striatal medium spiny 
neurons, in turn, enlargens the influx of calcium in the striatal medium spiny neurons. 
Thus, ACh in the striatum has a role in controlling intracellular levels of calcium in 
medium spiny neurons. Therefore, ACh in striatal interneurons serves a significant role in 
modulating chemical activity in this brain region. 
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DA has a differential effect on the activity of ACh interneurons depending upon 
which DA receptors are activated (Blanchet F. et al., 1997). For example D 1 receptors 
facilitate the release of ACh whereas D2 receptors inhibit ACh release (Blanchet F. et al., 
1997). Differential effects on behavior in DA receptor deficient mice have also been 
noted, with D2 receptor deficient mice expressing behaviors that resemble Parkinsonian 
symptoms, whereas D 1 receptor deficient mice do not (Baik JH et al., 1995; Drago J. et 
al., 1994). Since D2 receptors inhibit ACh release, the question arises in the D2 receptor 
deficient mice if it is the absence ofD2 receptors that affects motor behavior directly or 
whether it is through an indirect effect of D2 receptors on cholinergic interneurons. It is 
important to understand if ACh or DA has a more dominant role in affecting motor 
behavior because such insight may provide a better therapeutic regiment for PD. 
Taken together, ACh has two significant roles in the striatum. ACh interneurons 
appear to have a modulatory role in stabilizing the physiological states of striatal neurons 
and they also have a role in regulating NMDA responses on medium spiny neurons 
(Guebellini P. et al., 1998). The role of ACh in the striatum is one that is central to the 
physiology of the basal ganglia and therefore may be intimately involved in the onset of 
LID. 
Striatum: Matrix and Striosomes 
The striatum, based upon its neurochemical design, has been separated into two 
fundamental compartments: the matrix and the striosomes (Graybiel AM et al., 2000). 
Most of past and current PD research has only considered the role of the matrix 
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compartments, where the cell bodies from the direct and indirect pathways are located, 
for exploring LID (Graybiel AM et al., 2001). The striosomes are surrounded by the 
larger matrix and its cells project to the dopamine containing neurons of the SNc (Figure 
4). Interestingly, neurons in the striosomes compartment are naturally activated by 
pulsatile stimulation ofDA receptors in response to new stimuli in the environment 
(Graybiel AM et al., 2000). But, exploration ofhow striosomes affect the cells of the 
matrix has been only marginally investigated (Graybiel AM et al., 2000). Therefore, 
investigating the influence of the striosome compartment on the matrix neurons could 
lead to a new understanding of the underlying mechanisms in LID. 
The matrix and striosome compartments have distinct afferent and efferent 
connections (Dure LS IV et al., 1992): The striosomes receive inputs from the prefrontal 
cortex, the insular cortex and the amygdala and the matrix receives its major input from 
the association and sensorimotor cortex (Dure LS [V et al., 1992). Striatal circuitry 
differs for efferent connections from each compartment as well; striosomal neurons 
project primarily to the SNc whereas the matrix neurons project to the GPe, GPi and SNr. 
Ligand binding for the D 1 receptor subtype is more pronounced in the striosomes as is 
acetylcholinesterase histochemistry. Conversely, D2 receptor binding and 
immunostaming for tyrosine hydroxlase are more concentrated in the matrix (Graybiel 
AM and Langer LF, 1989). Therefore, D 1 receptors and ACh are more prominent in the 
striosomes compared to D2 receptors which are contained in the matrix. 
The potential influence of the striosomal pathway on the basal ganglia has largely 
been overlooked, but it may hold significance since this pathway is in a position to 
regulate input to the striatum. This is a key point because the activity of the striosomal 
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pathway could have a direct effect on motor behavior because the projections from the 
striosomal pathway reach the SNc where they could influence the DA projection back to 
the striatum (Graybiel AM et al., 2000). To date, major theories ofPD and LID take into 
account only the direct and indirect pathways that primarily comprise the matrix 
compartment ofthe striatum without considering the possible effects of the striosomal 
pathway on LID. 
e 
Motor 
output 
Figure 4. (modified from Graybiel AM et al., 2000) n1ree Pathway Model in the Basal 
Ganglia: The striosomal pathway: through the striosomal compartment of the striatum to 
the SNc. The direct pathway: through the matrix compartment of the striatum to the GPi 
& SNr and then to the thalamus and neocortex. The indirect pathway: through the rnatrix 
compartment of the striatum to the GPe, then to the STN, and to the GPi & SNr and then 
to the thalamus and neocortex. The nigrostriatal pathway that leads from the SNc to the 
striatum which degenerates in PD is also depicted. 
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However, because the DA pathway of the SNc is destroyed in PD, there must be 
another means for the striosomes to interact with the matrix after the onset of PD. One 
candidate serving as a link between the striosome and matrix compartments is the ACh 
interneuron. Even though cell bodies of the ACh interneurons are primarily located in the 
matrix compartment, their extensive neurites innervate both the matrix and the striosomes 
of the striatum (Calabresi P. et al., 1998). In addition, the density of ACh intemeurons is 
about twice a high in regions where the matrix borders the striosomes (Blanchet F. et al., 
that ACh interneurons are in the position to 
serve a role in transferring information from one striatal compartment to another. 
Therefore, it is plausible that ACh interneurons may serve as a communicator between 
the striosomal pathway and medium spiny neurons that comprise the matrix (Figure 5). 
In the intact basal ganglia, another way for the matrix and striosomes to interact is 
through the SNc. The striosomal pathway extends from the striosomes in the striatum to 
the SNc and is activated with pulsatile DA treatments. The neurons from the SNc then 
project to the matrix in the striatum through the nigrostriatal pathway, thus the activation 
of the striosomal pathway could enhance the activation ofthe nigrostriatal pathway and 
influence the matrix of the striatum. However, in DA denervated SNc that characterizes 
PD, this arrangement seems less likely. 
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Figure 5: (modified from Blanchet F et al., 1997)ACh borders the Matrix and 
Striosomes in the 5'triatum. Striosomes (S] and matrix (iVfx:) compartments are separated 
by ACh interneurons which may serve as a communicator between compartments. Both 
compartments have GABA projection neurons. The striosomes are comprised of mainlv 
D 1 DA receptors that facilitate cAMP activation and the matrix has both D l DA (direct 
pathway) and D2 DA (indirect pathway) receptors. The striosomes could influence the 
matrixfollowing levodopa treatment by acting via the ACh intcrneurons and affecting the 
medium spiny neurons (that contain NMDA and AMPA receptors) of the matrix. 
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CHAPTER2 
BASAL GANGLIA RESEARCH: MEMORY AND MOTOR STUDIES HAVE 
BEEN KEPT SEPARATE 
ACh has been recognized as an important molecule in learning and memory 
(Calabresi P. et al., 1998). Since the striatum has the highest concentration of ACh found 
in the brain, it seems likely that the basal ganglia are an area where ACh may be 
positioned to secure new memories (Calabresi P. et al., 1998). In the past, basal ganglia 
research has traditionally maintained two separate tracks of scientific investigation 
(Graybiel AM et al., 1998). One track has been focused on the role ofbasal ganglia in 
learning and memory, and the other track pertains to the role of the basal ganglia in the 
control of movement (Graybiel AM, 1998). However, minimal research has focused on 
the potential connection between these two tracks. The current explanations of UD as a 
purely motor abnormality are evident in this separation of research tracks because there is 
minimal investigation into the possibility that alterations in long-term memory patterns in 
the basal ganglia underlie the origin of LID. The next section will discuss each of the two 
research tracks, the roles of the basal ganglia in learning and memory and the control of 
movement, first separately and then in the context of an argument for the relationship 
between the two. It may be that the relationship between learning and memory and motor 
behavior could convey new insights into PD treatments and LID. 
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Basal Ganglia and Motor Control: The Current Model of PD and LID 
The role of the basal ganglia in motor control has largely been viewed from a 
clinical standpoint. Much research has been focused on how to understand and therefore 
treat motor disturbances of the basal ganglia. PO is the most common motor disorder that 
affects these brain structures (Jellinger KA, 2001 ). The motor dysfunction observed in 
PO is the result of a decrease in DA in the SNc. These DA neurons normally project from 
the SNc to the striatum forming the nigrostriatal pathway (Pollack AE, 2001). Although a 
small percentage of DA neurons naturally die off as part of the aging process, the DA 
levels in PO are reduced to 30% of their normal concentration ( 5-l OnM) in the striatum 
(CaJon F. et al., 2000; Yahr MD, 1993). The reduction in DA in the striatum, in turn, 
decreases the activity in the direct pathway and increases the activity in the indirect 
pathway (Graybiel AM et al., 2001 ). Since the direct pathway has an inhibitory effect on 
the basal ganglia output, SNr/GPi, therefore more inhibition directed to the thalamus 
(Figure 2). In contrast the indirect pathway has an excitatory connection to the GPi/SNr 
via the STN (Gerfen CR et al., 1990). The loss of DA in the indirect pathway results in 
less inhibition on the STN which leads to more excitation to the GPi/SNr output 
structures and greater inhibition on the thalamus (Gerfen CR et al., 1990). Since the basal 
ganglia output, GPi/SNr, has an inhibitory connection to the thalamus, changes in the 
activity of both direct and indirect pathways as a result of DA depletion, produces further 
17 
inhibition of the thalamus which, in tum, decreases thalamic excitation of the motor areas 
of the cortex (Gerfen CR et al., 1990). This results in a decrease in motor activity. 
The most commonly used symptomatic medical treatment for PD is levodopa, the 
chemical precursor to DA, which after years of treatment often results in the disabling 
side effects of uncontrollable, involuntary movements known as UD (Caton et al., 
2000). Existing theories on the manifestation of LID have been based upon clinical 
observations of PD patients as well as on animal models of PD. One theory of UD is 
based upon experiments that used an animal model of PD in which monkeys were treated 
with 1-methyl-4-phenyl-l ,2,5,6-tetrahydropyridine (MPTP) and then given chronic 
levodopa treatment. The results indicated that the abnormal movements observed after 
chronic treatment with Ievodopa were a result of the reduced activity in the GPi/SNr 
(Obeso JA and Okanow CW, 2000). Levodopa treatment was thought to cause too much 
inhibition of the projections from the striatum to the GPe neurons, which result in 
excessive inhibition of the STN, which, in tum, reduces the excitatory input to the 
GPi/SNr (Obeso JA and Okanow CW, 2000). The reduced activity ofthe GABA neurons 
in the GPi disinhibits the thalamus resulting in an increase in the activity of the 
thalamocortical inputs (Obeso JA and Okanow CW, 2000). This increase in 
thalamocortical inputs could result in LID because amplified inputs promoting movement 
would be sent from the thalamus to the cortex (Obeso JA and Okanow CW, 2000). 
However, this theory is flawed because when the GPi is lesioned it improves UD and PD 
motor functions suggesting that a decrease in GPi activity does not account for LID 
(Calabresi P. et al., 2000). 
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A second theory of LID suggests that it is due to the overactivity of the STN and 
that treating with glutamatergic antagonists will relieve the LID because of the potential 
of these antagonists to inhibit the excitatory effects of the STN on the output structures, 
GPi/SNr (Wichmann T. et al., 1994). However, because the effect of systemically 
administered glutamate antagonists is not localized to one specific region of the basal 
ganglia, these glutamate antagonists could be working to inhibit glutamate receptors 
involved in memory formation and not on the glutamatergic pathway from the STN to the 
GPi/SNr. In fact, motor fluctuations have been found to be dramatically reduced in 6-
0HDA lesioned , levodopa treated rats when injected intrastriatally with the NMDA 
antagonist, MK801 (Calabresi P. et aL 2000). This suggests the glutamate activity 
responsible for motor fluctuations is localized in the striatum. 
A third hypothesis for a mechanism underlying LID, the subject of this thesis 
posits that the pulsatile administration oflevodopa in the DA depleted striatum interacts 
with ACh and glutamate and produces a change in the amount of calcium influx into 
striatal medium spiny neurons, which in tum, intensifies the strengthening of synapses on 
medium spiny neurons. This synaptic change may activate pathways and cellular 
mechanisms similar to those involved in forming long term memories in the basal 
ganglia. This thesis examines the possibility that LID are a manifestation of a long term 
memory pattern via synaptic mechanisms that occur during learning and memory in the 
basal ganglia. Such mechanisms are hypothesized to be induced by DA denervation and 
subsequent chronic levodopa treatment that, in turn, leads to the abnormal motor behavior 
that characterizes LID. 
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Cortex 
Figure 6: (modified from Obeso JA and Olanow CW, 2000) Connection Differences in 
Nonnal, PD and LID Basal Ganglia. A) normal, B) PD and C) LID basal ganglia can be 
seen in the diagram. of lines and arrow heads indicate amounts of activity. Bold 
lines represent an increase in activity, thinner and smaller arrow heads indicate a 
reduction in activity. 
What has been clearly realized is that the development of LID depends on two 
main factors: pulsatile administration of DA replacement therapy and the degree of DA 
denervation (Hirsch E, 2001 ). Studies comparing intermittent levodopa administration to 
continuous DA administration showed LID does not arise with continuous levodopa 
administration (Calabresi P. et al., 2000). Continuous pharmacological stimulation ofDA 
receptors results in desensitization of motor behavior whereas intermittent stimulation of 
these receptors produces increased sensitization of motor behavior (Calabresi P. et al., 
2000). When rats are administered the DA agonist, apomorphine, their locomotive 
responses differ depending upon how the apomorphine is administered (Castro R. et al., 
1985). Castro R. et al. ( 1985) compared DA denervated rats receiving continuous 
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administration of apomorphine and noted the locomotive responses increases after 
intermittent injections as opposed to continuous administration. In contrast, the 
locomotive effect of apomorphine declines when the following injection is given before 
the preceding dose is completely metabolized. In addition, the greater the DA depletion, 
the larger the motor response to DA pulsatile administration (Castro R. et al., 1985). 
Speculations on why this may be are presented below. 
Early studies of neuronal activity in the SNc noted a slow and steady firing rate of 
DA neurons which serve to produce stable movements (De Long R. et al., 1983). This 
observation suggests that the SNc exerts a tonic (i.e. continuous) influence on basal 
ganglia circuits (Obeso JA and Olanow CW, 2000). Under normal circumstances in the 
intact striatum, DA receptors on striatal neurons are at a basal level of continuous 
activation (Calabresi P. et al., 2000). In the DA depleted system ofPD, the synaptic 
terminals that store and regulate the release of DA grow dependent upon the peripheral 
supply of exogenously administered levodopa (Caton F. et al., 2000). With increasing 
loss ofDA in advancing PD, there is a dramatic loss of DA terminals as well as greater 
difficulty in buffering the fluctuations in plasma levels of levodopa (Obeso JA and 
Olanow CW, 2000). In such instances, fluctuations in the plasma concentrations of 
levodopa may expose DA receptors to alternating high and low concentrations ofDA, 
therefore disrupting the continuous activation ofDA receptors observed in a normal 
system (Obeso JA and Olanow CW, 2000). However, because levodopa has a short half 
life in circulation it must be administered in a chronic intermittent fashion (Figure 7) 
(Graybiel et al., 2000). 
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Pulsatile stimulation ofDA receptors in the striatum has clearly been implicated 
in the onset of LID, however, the exact mechanism underlying LID remains unclear 
(Obeso JA and Olanow CW, 2000). What is known is that DA concentration in the intact 
nigrostriatal pathway, is at a constant level and is maintained with little variation (Calon 
F. et al., 2000). 
Dopamine/ 
PERIPHERAL CENTRAL 
Figure 7: (modified from Koller WC, 2000) Levodopa and absorption in the PNS and 
CNS. Central nervous system relies on the periphery for DA supply. The diagram depicts 
levodopa being administered in the periphery and transformed into DA once it crosses 
the blood brain barrier (BBB) and enters the central nervous system. 
Therefore, pulsatile administration oflevodopa contrasts dramatically with this 
continuous flow ofDA in the intact striatum. However, recent studies have suggested a 
link between the onset of LID and activation of the striosomes in the striatum (Graybiel 
AM et al., 2001 ). Past research has shown that the striosomes are involved in the 
processing of long-term memory of reinforcement/stimulus response and reward learning 
(Graybiel AM, 2000). In fact, pulsatile release ofDA and subsequent DA receptor 
stimulation in the striosomes occurs naturally during theses types of learning in the basal 
ganglia (Graybiel AM, 2000). Therefore, the pulsatile stimulation induced by levodopa 
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treatment for PD may activate the same region in the basal ganglia involved in 
reinforcement and stimulus/response learning, the striosomes, and subsequently affect the 
activity of the medium spiny neurons of the matrix. A closer look into how the 
reinforcement and stimulus/response mechanisms function in the basal ganglia may shed 
some insight into what may be occurring during repeated levodopa treatments and 
subsequent LID in PD. 
Basal Ganglia in Learning and Memmy 
In recent decades investigation of the basal ganglia has become an active area of 
research in the study of learning and memory (Compton, 2001 ). For example, studies 
have substantial evidence that supports the claim that the basal ganglia plays a significant 
role in the formation of habits and in stimulus/response learning (Compton DM et al., 
2001 ). Researchers have found that the basal ganglia provide a pathway, the striosomal 
pathway, that allows the coupling of sensory information/stimuli with a conditioned 
motor behavior (Calabresi P. et al., 1997). Inputs to the striosomes are primarily routed 
from the prefrontal cortex, insular cortex and the amygdala (Dure LS IV et al., 1992). 
These same regions are important in processing memory (Dure LS IV et al., 1992). An 
example of stimulus/response and habitual learning was provided by Pavlov's classical 
conditioning experiments which was the first model of learning studied in psychology 
(Mackintosh, 2003 ). Pavlov trained dogs to salivate at the sound of a bell by forming a 
reflexive behavior to a newly learned association. During the training period a bell 
became the "conditioned" stimulus for the dogs following repetitive trials of food 
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rewards after the bell was sounded (Mackintosh NS, 2003). A newly learned association 
was expressed by behavior. Similarly, the reinforced behaviors on a cellular level appear 
to be processed in the striosomes (Graybiel AM et al., 2000). After Pavlov, some of the 
earliest work in stimulus/response learning was done by Divac I. (1967, 1968) who 
showed that lesions in various parts of the caudate nucleus in rats, monkeys and cats 
impaired memory retention. In attempts to train rats to respond by lever presses by using 
light as the stimulus and food as a reward for pressing, rats with caudoputamen lesions 
were unable to retain this information (Divac I., 1967). Such findings are consistent with 
memory consolidation for stimulus/response learning occurring in the striatum which 
supports the idea that learned stimulus/response information is held in a labile state and 
may be influenced for a brief period following its initial acquisition (McGaugh JL and 
Herz MJ, 1972). These observations led to the belief that some functions of the caudate 
(striatum) cannot be explained by mere sensory and motor systems alone but rather that 
memory was involved for learned motor behavior (Packard, MG. et al., 1989). White NM 
et al. ( 1996) presented evidence that the dopaminergic nigrostriatal pathway was involved 
in the consolidation of memories. In addition, Divac I. (1968) showed that posttraining 
injections ofDA agonists into selective regions ofthe caudoputamen increased retention 
of memory tasks. Such work is suggestive that DA in the caudoputamen is necessary in 
forming conditioned responses through reinforcement. In fact, distinct parts of the 
caudoputamen may differ in their memory-related functions (Graybiel AM, 1995). The 
medial part of the caudoputamen has been associated with conditioned reward responses 
and the lateral part is correlated with stimulus/response learning (Graybiel AM, I 995 ). 
Thus, distinct regions of the striatum are associated with different learning processes. 
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Similar to stimulus/response learning is the concept of conditioned reward 
responses in the basal ganglia. Anticipation of conditioned rewards as a form of memory 
was studied by Schultz W. et al. (1997) in the DA neurons ofthe nigrostriatal pathway. 
The reward pathway is activated by DA pulsatile stimulation. Once this DA pulsatile 
activation has begun, the brain is prepared to receive novel stimuli. TheDA neurons were 
activated by unanticipated reward stimuli compared to conditioned stimuli where rewards 
were expected. In the cases where rewards were expected the DA neurons were not 
activated. Assessment of reward stimuli is proposed to work by the activation of phasic, 
that is, pulsatile, not continuous, DA activity (Schultz W., 1997). Therefore, the initiation 
of this phasic DA activity would indicate novel reward stimuli and errors with respect to 
the normal/conditioned reward responses. These prediction errors would be translated as 
new situations leading to rewards that would require the learning of a novel stimulus 
(Schultz W., 1997). DA would be released in response to this new stimulus and serve to 
reinforce and consolidate it (Figure 8) (Schultz W., 1997). Such activity is similar to what 
occurs in LID which is also a manifestation of pulsatile DA activation in the basal 
ganglia. Recent research presents evidence that the striatum is differentially activated 
dependent upon the learning of new or familiar behavioral routines (Graybiel AM, 1995). 
Studies that support the differential activation of the striatum found that novel behavior/ 
new learning takes place in the anterior striatum (i.e. caudate nucleus), whereas pre-
learned or repetitive tasks activate the posterior striatal regions (i.e. putamen). Based on 
these data, it is clear that the basal ganglia seem to have a strong role in forming types of 
memory involved in conditioned responses. In order to understand how these memories. 
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could be formed on a cellular level, it is helpful to review some current theories on the 
molecular basis of forms of memory mechanisms 
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Figure 8: (modified from Graybiel AM, !995). Learning and Erpression of Behavioral 
Routines Flow Chart. A) Information inputs from the prefrontal cortex, limbic system and 
SNc are processed through the striatum. Processing through pallidonigral-subthalamic 
circuit1y differentiallv activates programs that are sent to the cerebral cortex and to 
pattern generators in the brain stem/spinal cord. As time progresses these programs 
build behavioral routines. Pale squares in the striatum indicate striosomes, which are 
more prominent in the caudate nucleus. 
B) Once behavioral programs are learned, their behavioral sequences are ready to be 
expressed. Information about action plans are sent from the premotor/motor cortex and 
other inputs are sent from the parietal cortex which supplies sensorirnotorlspatial 
information which is then processed in the striatum (putamen and parts of the caudate 
nucleus). This activates selected programs through the pallidonigral-su.bthalamic 
circuitry which are sent to the cerebral cortex and to the brain stem/spinal cord. This 
system interacts with the learning system and is modifiable dependent upon evaluation 
signals that may be received by the SNc. The dark square in the striatum represents the 
striosomal organization of the putamen and caudate nucleus. 
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CHAPTER3 
HETEROSYNAPTIC PLASTICITY IN THE STRIATUM 
Synaptic plasticity is a long lasting change in the functional efficacy of synaptic 
transmission that is prompted by certain patterns of brain stimulation (Calabresi P.et al., 
2000). Long term memory has been hypothesized to be a function of this synaptic 
plasticity (Silva MA et al., 1997). Therefore, synaptic plasticity occurring in the striatum 
may be modulated by the basal ganglia (Calabresi P. et al., 1996). In the most general 
terms, synaptic plasticity can be broken down into two basic components, homosynaptic 
plasticity and heterosynapic plasticity (Blais BS et al., 1999). Homosynaptic plasticity 
involves a single synapse, which with repeated activation either becomes stronger or 
weaker (Blais BS et al., 1999). In heterosynaptic plasticity, activity in one neuron 
modulates activity in another by either increasing or decreasing its presynaptic strength 
(Blais BS et al., 1999). The presynaptic strength would be increased if action potentials 
are positively correlated with the postsynaptic cell activity and decreased if the action 
potentials are not correlated with the postsynaptic cell activity. The basic idea in 
heterosynaptic plasticity is that the synaptic strength of one neuron is modified by the 
activity in another neuron (Houk JC, 1995). 
In the basal ganglia, heterosynaptic plasticity could be demonstrated by the 
striosomal projection neurons possibly affecting the activity of the matrix neurons at 
several potential locations. The most probable of these sites is through the ACh 
intemeurons that line the border between the matrix and striosomes. 
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As stated earlier, the striatal output neurons comprise two distinct compartments, 
the striosomes and matrix, with ACh intemeurons located at the striosome/matrix border 
(Graybiel AM et al., 2000).This anatomical arrangement may allow the striosomes to 
influence, via ACh intemeurons, the projection neurons in the matrix that comprise the 
direct and indirect pathways. This synaptic organization illustrates on a cellular level how 
reinforcement by heteroynaptic plasticity might work (Houk JC, 1995). 
While DA has been associated with positive reinforcement, such memory 
mechanisms contributing to LID have been marginally investigated. Positive 
reinforcement could activate a heterosynaptic plasticity mechanism in the basal ganglia. 
In principle heterosynaptic plasticity combines three factors: presynaptic activity, 
postsynaptic activity and a neurochemical reinforcement (Houk JC, 1995). A 
neurochemical reinforcement refers to the release of a chemical agent during the 
reinforcing activity. Such neurochemical reinforcement has been attributed to 
monoamines, such as DA (Calabresi P. et al., 2000). Studies have demonstrated that the 
release of monoamine neurotransmitters from one group of neurons can influence long 
term changes in transmission efficiency in another group of neurons, even if the 
neurotransmitter used in the both pathways are not the same (Houk JC, 1995). For 
instance DA in one pathway could influence glutamate cell activity in another pathway. 
In generaL heterosynaptic plasticity is facilitated by a monamine mediated increase of the 
intracellular concentrations of cAMP (Houk JC, 1995). For example, Frey U. et al. (1993) 
found that a brief application of a cAMP analog induces a long lasting potentiation in the 
neurons of the striatum. Activation of D 1 receptors which promotes an increase in cAMP 
may be responsible for heterosynaptic long term changes in synaptic efficacy of medium 
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spiny neurons in the striatum (Houk JC, 1995). Bouyer 11 et al. ( 1984) found that striatal 
afferents from the cerebral cortex and DA afferents from the SNc often terminate in close 
proximity to one another, their synapses are often on the same dendrites and/or on the 
same dendritic spines. Tyrosine hydroxylase (TH) staining showed that these DA 
synapses found on dendrites and spines were located on the striatal medium spiny 
neurons (Freund TF et al., 1984). Thus, the convergence of dopaminergic, glutamatergic 
and cholinergic synapses on medium spiny neurons includes the criterion for 
heterosynaptic modification. Following DA denervation, levodopa administered in a 
pulsatile manner could possibly activate the striosomes, thereby disrupting the normal 
synaptic mechanism in the striatum (Graybiel AM, 2000). In tum, the striosomal 
compartment could influence the medium spiny neurons of the matrix by acting through 
the ACh intemeurons. The potential influence of the striosomes on the matrix via the 
ACh intemeurons would incorporate factors necessary to form heterosynaptic plasticity 
resulting in the production of long term memory. 
L TP and LTD in the Striatum 
The heterosynaptic arrangement of striosomes, ACh and the matrix in the striatum 
allows for a bimodal (i.e., weak or strong) stimulation mechanism to change synaptic 
efficacy. The two most fundamental molecular theories oflong term memory formation 
are long term potentiation (LTP) and long tenn depression (LTD). LTP is an increase in 
synaptic strength whereas LTD is a reduction in synaptic strength (Baudry M. et al., 
1993 ). Research suggests there are no synapses exclusively expressing L TP or LTD, 
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instead, plasticity in synapses is evoked by either strong stimulation in the case of LTP or 
weak stimulation in the case ofLTD (Calabresi P. et al., 1996). Such stimulation would 
proceed upwards (L TP) or downwards (LTD) in an extended continuum ( Calabresi P. et 
al., 1996; Linden DJ, 1998; Zucker RS et al., 1989). On a molecular level, stimulation 
intensity determines the amount of calcium influx, which in tum, determines whether 
L TP or LTD is triggered (Figure 9) (Zucker RS et al., 2001 ). Therefore, the amount of 
intracellular calcium determines the bimodal state ofheterosynaptic plasticity: a lesser 
amount of calcium influx triggers LTD whereas a more substantial amount of calcium 
influx triggers L TP (Bailey CH et al., 2000). This mechanism may allow for memory 
storage to be organized in an array of synaptic weights of different strengths. Synaptic 
connections may be driven to their minimal (LTD) and maximum (L TP) strengths within 
the neural array and may function to contribute to the regulation of synaptic plasticity by 
determining the synaptic connections to present the state of L TP or LTD based upon the 
amount of calcium influx (Berke JD and Hyman SE, 2000). Both LTD and L TP 
mechanisms have the potential to be expressed in the striatum because of the low 
excitability of striatal neurons. However, the normal synaptic mechanism in the striatum 
favors LTD, with LTP rarely expressed (Calabresi P. et al., 1997; Hirsch E, 2001). LTD 
and LTP both requires activation of striatal glutamate and DA receptors (Calabresi P. et 
al., 1994). LTD is triggered in striatal neurons when DA receptors are activated in 
addition to AMPA receptor activation, while L TP is triggered when DA agonist 
administration is accompanied by NMDA glutamate receptor activation. This may be due 
to NMDA receptor's influence on calcium influx. 
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Figure 9: (modifiedfrom Bailey CH eta!., 2000) Homosynaptic and Heterosynaptic 
Mechanisms. A) homosynaptic: synaptic strengthening occur at the same synapse as it is 
being strengthened. B) heterosynaptic: synaptic strengthening between a presynaptic and 
postsynaptic cell results as a third neuron, a modulatory interneuron, regulates the 
strength of the synaptic strength 
The state of synaptic plasticity, LTD or LTP, depends upon the amount of 
intracellular calcium in the striatum (Calabresi P. et al., 1994). AMPA and NMDA 
glutamate receptors appear linked to LTD and LTP, respectively. Therefore, it may be 
useful to analyze these glutamate receptors and assess what specifically in their 
individual structure determines these distinct functions to promote LTD or LTP. 
Castellani GC et al. (200 1) addressed these questions by the examination of subunit 
characteristics of AMPA and NMDA glutamate receptors. Previous studies had provided 
evidence supporting the idea that calcium concentration determines the state of synaptic 
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plasticity, LTD or LTP (Calabresi P. et al., 1994; Carrol FI et al., 1999). Studies have 
confirmed that high frequency stimulation (HFS) of presynaptic afferents leads to L TP 
whereas low frequency stimulation (LFS) of presynaptic afferents leads to LTD 
(Castellani GC et al., 2001). It has been suggested that subunits of AMPA receptors 
directly influence the amount of calcium influx and therefore serve as a regulating 
component ofthee bimodality of synaptic plasticity, LTD or LTP (Carrol FI et al., 1999). 
AMPA receptors are composed of subunits termed GluR1-GluR4 (Castellani GC et al., 
2001). Properties of AMPA receptors are dependent upon the composition of individual 
GluR l-GluR4 subunits and the phosphorylation/dephosphorylation state of the subunit 
proteins (Castellani GC et al., 2001 ). Specific sites on these AMPA subunit proteins have 
been linked to synaptic plasticity, e.g. Serine 831 (S-831) and Serine 845 (S-845) on the 
GluRl subunit which can be phosphorylated by CaMKII/protein kinase C and protein 
kinase A, respectively (Carrol FI et al., 1999). Expression of L TP correlates with a two-
fold increase in phosphorylation of S-831 and the expression of LTD is correlated with a 
decrease in the phosphorylation ofS-845 (Carrol FI et al., 1999). Therefore, knowing the 
phosphorylation states the effect they have on L TD/L TP expression may help predict the 
state of synaptic plasticity. For example, if L TP is correlated with an increase in 
phophorylation of S-831, then removing the phosphate at this particular site may block 
L TP expression. 
NMDA receptor antagonists inhibit the induction ofboth LTP and LTD that 
suggests that NMDA receptors may be an entry point for calcium in the postsynaptic 
neuron. This in tum would affect the state of synaptic plasticity (Castellani GC et al., 
2001 ). NMDA receptors are composed of the subunits: NRI and NR2. NR2 subunits 
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have four distinct subtypes, 2A-2D, which have specific functions for mediating ionic 
currents in the NMDA receptor (Castellani GC et al., 2001). NRl and NR2B subunits 
mediate currents at ~ 250 milliseconds whereas NR2A subunit mediates faster currents at 
~50 milliseconds (Castellani GC et al., 2001 ). Castellani GC et al. (2001) presented a 
model which combines the changes of AMPA receptors with the changes ofNMDA 
receptors in order to predict the directionality of synaptic plasticity, LTD or LTP, based 
upon the amount of intracellular calcium present within the system being measured. The 
combination of particular subunits on glutamate receptors caused modality changes in the 
synaptic plasticity. A similar case may be true in the striatum because neurotransmitters 
that seem to have a role in synaptic plasticity in the striatum are DA, glutamate and ACh. 
These are the neurotransmitters found in the pathway leading from the striosomes > ACh 
intemeurons matrix. However, the interaction of these neurotransmitters and their 
on calcium levels in the medium spiny neurons in the striatum has not been 
investigated. If their interaction can be shown to affect calcium levels in the striatum, 
then it is likely that L TP expression in the striatum could be regulated and as a 
consequence LID suppressed. 
The imbalance that erupts in the basal ganglia between the DA and glutamate 
following DA denervation may contribute to the change in synaptic efficacy in the 
striatum (Calabresi P. et al., 2000). Following DA denervation, the striatum experiences 
an elevation in both glutamate and ACh (Starr MS, 1995). Both of these 
neurotransmitters are modulated by DA (Starr MS, 1995). Thus as DA levels decrease in 
the striatum, so does DA's ability to modulate glutamate and ACh. An increase in 
glutamate has been proposed to compensate for the depletion of DA in the striatum (Starr 
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MS, 1995). The increase in glutamate causes excitation in the striatum whereby the 
striatal neurons enter the depolarized state and NMDA receptors are activated. The 
NMDA receptor activation allows more calcium to enter the cells for L TP to be 
expressed. This disruption of striatal neurotransmitters leads to a difference in synaptic 
efficacy in medium spiny neurons that is modulated by an increase in intracellular 
calcium levels that results in L TP expression. 
Following DA denervation, LTD in the striatum is no longer expressed and 
chronic pulsatile administration of levodopa treatment produces L TP in the striatum 
(Calabresi P.et al., 2000). Calabresi P. et al. (2000) hypothesizes that after DA 
denervation the L TP that is induced by pulsatile levodopa involves a change in gene 
expression that leads to altered metabolic functions of postsynaptic striatal neurons 
(Figure 1 0). These altered metabolic functions would ultimately result in apoptosis 
(Calabresi P. et al., 2000). Additional alterations noted in Calabresi's (2000) 
investigations were changes in NMDA subunits that alter phosphorylation processes and 
correlate with LID. Activation of these altered subunits would cause an extensive 
elevation in intracellular calcium in striatal spiny neurons, leading to an alteration of the 
metabolic state of the cell. These alterations have been thought to promote depolarization 
and further NMDA receptor activity in a cyclical manner that is correlated with apoptosis 
(Calabresi P. et al., 2000). 
Since D2 receptors have a regulating function over glutamate and DA release, the 
role of the D2 receptors in regulating synaptic plasticity has been examined. Maura G. et 
aL (1988) showed that D2 receptors and possibly D4 (D2 like) receptors are located on 
corticostriatal terminals and these receptors inhibit the release of glutamate. Calabresi P. 
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et al. ( 1997) compared 02 receptor knock out mice to wild type mice to further 
investigate the role of DA receptors in synaptic plasticity. Since HFS has been previously 
shown to induce synaptic plasticity in the cerebral cortex, Calabresi P. et al. ( 1997) 
decided to use HFS to investigate LTD and L TP in striatal brain slices. In vitro HFS of 
brain slices from wild type mice produced LTD, whereas this same stimulation in slices 
from D2 receptor deficient mice produced LTP. This seems to suggest that in D2 receptor 
deficient mice, either there is a change in synaptic efficacy following repetitive activation 
by HFS of corticostriatal projections or that 02 receptors are required for LTD. Freedman 
JE and Weight FF (1988) found postsynaptic D2 receptors are capable ofblocking cAMP 
activation, activating potassium channels and preventing calcium currents from entering 
isolated striatal neurons. This suggests that 02 receptors may be associated with LTD and 
in the absence of D2 receptors L TP is expressed in the striatum. Therefore, D2 receptors 
could serve to suppress calcium influx in the striatum so that in their absence, calcium 
influx occurs and subsequent LTP is produced. Drago J. et al. (1994) reached similar 
conclusions during experiments that explored the effects of D 1 and D2 receptor deficient 
mice on motor behavior. While Dl receptor deficient mice have normal coordination and 
mild hyperactivity (Drago J. et al., 1994), 02 receptor deficient mice present with motor 
symptoms of PD (Baik JH et al., 1995 ). These data indicates that D2 receptors play an 
instrumental role in long term changes in synaptic efficacy in the striatum and may be 
necessary for LTD expression in the striatum. 
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Figure 10: (modifiedfrom Calahresi P. et al., 2000) Long Terrn Mechanisms Following 
Acute and Chronic Treatment tvith Levodopa. The top half of the diagram depicts DA 
dencrvation plus acute levodopa treatment, LTD is produced when striatal neurons are 
hyperpolarized (refererred to as "down" state in diagram) and l'ilifDA receptors are 
inactive. No LTP is produced during acute levodopa treatment. The bottom half of the 
diagram illustrates chronic levodopa treatment post DA denervation. NMDA receptor 
activation plus striatal neurons in the depolarized state produce LTP and LID. NJ.,1DA 
inactivation and striatal neurons in the hyperpolarized state produces LTD and no LID. 
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CHAPTER4 
CORRELATIONS BETWEEN MEMORY AND MOTOR PATTERNS IN THE 
BASAL GANGLIA AND THE ONSET OF LID 
Until very recently, most basal ganglia research has not investigated in depth the 
possibility that LID, which greatly compromises the effectiveness ofPD treatments, 
could be the result of a memory pattern generated in the basal ganglia. When DA 
denervation occurs in PD, the normal continuous flow ofDA to the striatum is 
interrupted. At the same time levels of glutan1ate and ACh increase within the striatum. 
DA has a modulatory role over both of these neurotransmitters and it is also hypothesized 
that the increase in glutamate serves a compensatory role in the striatum when DA levels 
decline (Starr MS, 1995). This change in the neurochemistry of the basal ganglia 
following DA depletion causes the striatal neurons to transition from a hyperpolarized 
state to a depolarized state. As a result of this transition, NMDA receptors on medium 
spiny neurons are activated and this fosters an elevation in calcium influx in the medium 
spiny neurons ofthe striatum leading to either LTP or LTD. What is not known is to what 
degree the interactions among ACh, DA and glutamate regulates intracellular calcium 
influx in the medium spiny neurons. In addition, Dl receptor activation in the neurons of 
the striosomes and the matrix produces an increase in cAMP production in the medium 
spiny neurons of the striatum. The result of ACh interneurons mediated calcium influx 
may activate PKC and PKA kinases associated with cAMP responsive-element binding 
protein (CREB) transcription changes (Silva et al., 1997). Transcription factors are 
nuclear proteins that bind to specific base sequences of DNA in the regulatory regions of 
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particular genes so as to regulate their expression. Both the production of cAMP by D l 
receptor activation and the increase in calcium can activate CREB transcription factors 
(Silva MA et al., 1998). Memory mechanism, in particular, LTP, have been linked to the 
activation of CREB transcription factors (Silva MA et al., 1997). Such protein synthesis 
and gene expression changes are necessary elements in long term synaptic changes that 
are the necessary for long term memory (Silva MA et al., 1997). The molecular changes 
that produce long term synaptic changes within the striatum are essentially unknown 
(Calon F. et al., 2000). Molecular changes have been observed in the hippocampus during 
L TP but there is no conclusive evidence that specific transcription factors produce a form 
of long tem1 memory that is manifested as LID in the striatum (Figure 11 ). 
The underlying mechanism for the interaction between glutamate and DA in the 
striatum is not well understood, but evidence suggests their involvement in cAMP 
activation and the identity of sets of genes encoding transcription factors such as CREB 
which affect the expression of members of the Fos-Jun family oftranscription factors 
(Canales JJ et al., 2002). Expression patterns of immediate early genes (lEG) coding for 
the Fos-Jun family of transcription factors are activated during DA-glutamate interaction 
in the striatum (Canales JJ et al., 2002). Following DA denervation, the expression of 
lEGs changes throughout the course of chronic levodopa treatment and lEG expression 
shifts from the matrix region of the striatum to the striosomes (Figure 12). 
The shift in IEG expression in the striatum also correlates with the occurrence of 
LTD and L TP in the striatum. The cortical inputs to the matrix are innervated by the 
association cortex in the medial parts of the striatum and by the sensorimotor cortex in 
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the lateral parts of the striatum (Graybiel AM et al., 2000). Cortical inputs to the 
striosomes are innervated by the limbic system (Graybiel AM et al., 2000) 
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Figure 11: (modifiedfrom Calon F. et al., 2000) Flow of Molecular Events presenting 
LID as Abnormal Learning DA and glutamate interaction produce molecular events. 
LiD are depicted as a result oj"abnormallearning brought about by DA denervation and 
pulsatile L-Dopa treatment which elicits changes in the basal ganglia that result in 
poorlv regulated responses to DA agonists 
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Figure 12: (modified from Graybiel AM et al., 2000). Shift of lEG Expression from 
Matrix to Striosomes in Chronic Levodopa Treatment. Shaded areas are activated lEGs 
(Fos family) in response to levodopa treatment over time. A) activation of lEG 
expression is widespread in the striatum during acute levodopa treatment. B) activation 
of lEG expression is predominant in the striosome, as levodopa treatment becomes 
chronic and intermittently administered striatal DA is reduced substantially, but some 
DA still intact in the striatum. C) activation of lEG expression is found in the striosomes 
and in the medial striatum as levodopa treatment becomes chronic and intermittently 
administered and the striatal DA has become completely depleted. LID are correlated 
with medial striatum/striosome activation (Graybiel eta!., 2000). The dashed lines 
indicate areas where LTD is expressed and the bold lines indicate where LTP is 
expressed 
Acute levodopa treatment correlates with widespread lEG activation in the striatum 
(Graybiel AM et al., 2000). As chronic levodopa treatment proceeds over time a 
striosome predominant pattern of lEG activation emerges in the anterior and lateral 
striatum and LTP is expressed (Graybiel AM et al., 2000). Interestingly, NMDA 
glutamate antagonists have been shown to improve LID (Calabresi P.et al., 2000); their 
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effectiveness could be a consequence ofblocking the LTP mechanism that may be a 
direct result of limiting the calcium influx via NMDA receptors. Blocking the LTP 
mechanism in the striatum could then prevent the formation of the motor memories that 
constitute LID. Since all the neurotransmitter interactions needed to express striatal LTP 
are found in ACh intemeurons, it would be interesting to observe if cholinergic 
antagonists also have the potential to block striatal L TP. Indeed, cholinergic antagonists 
were the first effective therapeutic agents used to treat PD (Yahr MD, 1993). However, 
these anticholinergic treatments were eventually discontinued due to memory 
impaim1ents that PD patients encountered. As noted, DA differentially modulates ACh 
release through D 1 and D2 receptor stimulation (Calabresi P. et al., 1998). Following the 
loss ofDA in PD, ACh modulation is altered resulting in a substantial increase in the 
levels of ACh in the striatum. In fact, studies have suggested the oscillatory phase that 
striatal neurons present after DA depletion is the result of the increase in ACh which 
enables the depolarized state of the striatal neuron and produces L TP in the striatum 
(Burgard EC and Sarvey JM, 1990). Thus, by blocking ACh receptors, this may prevent 
L TP in the striatum from being formed and, in tum, LID that accompanies chronic 
levodopa treatment may potentially be controlled. 
Although monoamine mediated heterosynaptic plasticity has been studied in a 
number of neural systems, its potential to produce motor memories resulting in LID in 
the striatum has not been thoroughly explored. In other neural systems outside the 
striatum, the release of monoamine neurotransmitters from one set of synapses can elicit 
long term changes in efficacy of transmission in another set of synapses that use a 
different neurotransmitter (Schwartz and Greenberg, 1987). In many instances this 
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monoamine mediated heterosynaptic plasticity is brought about by the increase in the 
intracellular concentration of cAMP (Greenberg SM and Schwartz SH, 1987). In a wide 
range of species, these actions of monoamines underlie the storage of memory in the 
form of long lasting changes in synaptic efficacy (Greenberg SM and Schwartz SH, 
1987). Monoamines mediating the changes in synaptic efficacy in the striatum may be 
responsible for the striosomes producing heterosynaptic plasticity in the matrix through 
ACh interneurons. The striosomes have a large number of D 1 receptors that are known to 
increase cAMP responses. Therefore, levodopa acting in the striosomes synapses on the 
ACh interneurons, that in turn, synapse on neurons in the matrix. Since activation of D 1 
receptors increases cAMP, the pulsatile administration oflevodopa acting through Dl 
receptors in the striosomes may increase cAMP in the cells of the striosomes that, in turn, 
activates protein kinases leading to phosphorylation of lEG that activate Fos. Fos/Jun 
API complexes induce changes in NMDA receptor expression in the medium spiny 
neurons facilitated through ACh interneurons. These NMDA receptor changes would 
result in an increase in NMDA receptor activation that would subsequently trigger L TP in 
the medium spiny neurons. This example ofheterosynaptic plasticity would yield a 
change from LTD to L TP in the medium spiny neurons. 
In the striatum, there are several possible sites with an anatomical basis for 
heterosynaptic plasticity. The most probable place this heterosynaptic plasticity is taking 
place is on medium spiny neurons. Levodopa treatment activates the striosomes that, in 
turn, increases cAMP through D 1 receptor activation in the striosomes. The increase in 
cAMP activates lEG expression and when coupled with API complexes lead to NMDA 
receptor changes in the medium spiny neurons. Indeed medium spiny neurons express 
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DA, glutamate and mucarinic receptors and therefore a likely region for heterosynaptic 
plasticity to be expressed. 
DA denervation results in an increase in glutamate (Starr MS, 1995). Some 
investigators have examined the possibility that chronic levodopa treatment further 
changes NMDA and AMP A glutamate receptor populations in the striatum, but evidence 
has been inconclusive (Starr MS, 1995). Following DA denervation and chronic levodopa 
treatment, an increase in tyrosine residue phosphorylation on NMDA subunits which 
indicates an increase in NMDA receptor activation and possibly NMDA receptor 
concentration has been reported from animal experiments (Menegoz M. et al., 1995). 
Similar phosphorylation changes on NMDA subunits have been found during L TP 
(Rosemblum K. et al., 1996). It has been noted in postmortem analyses of PD patients 
that there is an increase in ligand binding to NMDA receptors suggesting an increase in 
glutamate function in the basal ganglia which is correlated with calcium influx and 
second messenger cascades (Ulas J. et al., 1994 ). However, it is not clear whether this 
increase in binding ofNMDA receptors is due to the DA depletion or the chronic 
levodopa treatment, but pharmacological evidence implies that an abnormal 
glutaminergic excitation in the striatum may contribute to the pathophysiology of LID 
(Papa SM et al., 1995). When an NMDA receptor antagonist, such as MK 801, is 
administered with levodopa to unilaterally 6-hydroxydopaminee lesioned rats, there is a 
substantial decrease in motor fluctuations (Papa SM et aL 1995); This effect is 
maximized when MK 801 is injected intrastriatally as opposed to systemically or injected 
into other regions of the basal ganglia (Marin C. et al., 1996). This suggests that 
glutamate acting in the striatum has a major role in inducing LID. Thus, ifNMDA 
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antagonists such as MK 801 were administered with levodopa, it might switch the striatal 
neurons to a hyperpolarized state and by doing so, induce L TO which is the normal long 
term memory mechanism in the striatum (Calabresi P. et al., 2000). Therefore, by 
switching the heterosynaptic plasticity to favor L TO over L TP, the objective would be to 
minimize LID. 
Because of the difficulty assessing new treatments for human diseases, 
noninvasive methods such as computer modeling have been employed in recent years in 
medical research. By designing an artificial neural network (ANN) to promote a bias in 
the modality ofheterosynaptic plasticity in the striatum to favor LTD it may be possible 
to limit striatal LTP and thereby control LID which occurs during levodopa treatment in 
PD. Because the location of the proposed heterosynaptic mechanism is not certain, an 
ANN should assess the neurotransmitters to evaluate the importance of ACh, glutamate 
and DA in producing striatal LTP. The effect each of these neurotransmitters has on LTP 
expression may provide insight into where the heterosynaptic plasticity is taking place. 
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CHAPTERS 
ARTIFICIAL NEURAL NETWORKS AS A RESEARCH TOOL IN 
PARKINSON'S DISEASE 
ANN are sets of algorithms that are modeled after the human brain (Hinton GE, 
1992). Generally speaking, they contain mathematical equations that model biological 
processes such as learning and memory. Such models representing brain functions 
provide an important tool in neuroscience research because they offer a noninvasive 
exploration into measuring neuronal function in human pathologies. Neural networks 
differ from other types of programming techniques in that they have the unique ability to 
learn mathematical relationships between a series of inputs and their corresponding 
outputs. For a better understanding of neural network models, Tu JV(l996) provides an 
adequate summary. A comparison between ANN and standard statistics is outlined below 
in Figure 13. One significant difference between statistics and ANN is the level of 
expertise needed in building models. 
In a standard statistical format there is a linear relationship between the 
independent and dependent variables. The ANN is designed to take complicated 
nonlinear relationships and find patterns between the input and output data. These 
di ffcrences can be depicted graphically by a diagram of a logistic regression model 
(Figure 14) and a basic ANN model (Figure 15). In the past ten years computational 
models of PD have begun to be used to complement other investigative methods. Current 
researchers have begun to see the importance of neural network modeling as a research 
tool in neuropharmacological investigations such as PD and therapeutic dosing 
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Figure 13: (modified from Tu JV 1996) Comparative Terms Between ANN and Standard 
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Figure 14 (modified from Tu JV, 1996) A Basic Logistic Regression Model. Logistic 
regression is a commonly used in statistical modeling. The probability of an outcome 
relates to a series of possible predictor variables. The usual assumption is that these 
predictor variables are related in a linear manner. This particular diagram is designed to 
predict the probability (p) of a patient dying from a hypothetical disease on the basis of 
the age (xi) and sex (x2) of the patient. The values of the beta coefficients are shown. 
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Figure 15: (modified from Tu JV 1996) A Basic ANN Model. Diagram of an ANN trained 
to predict the probability of a patient dying from a hypothetical disease on the basis of 
the age ('C l) and sex (x2) of the patient. Each circle represents a node, each line 
represents a connection weight. The nodes of the network are in three layers (input, 
hidden, output). A logistic activation fimction is used in both the hidden (hl, h2) and 
output (01). Hl and h2 are the activation of hidden nodes land 2 and the predicted 
output node OJ. At each hidden and output node, a weighted linear combination of the 
inputs is summed and then a logistic transformation is applied. 
Modeling the neural mechanisms that may be responsible for LID in PD may help to 
understand how the basal ganglia interact in healthy versus diseased subjects and may 
lead to experimental designs to verify theoretical methods. A variety of plausible 
mechanisms of drug action can be examined by designing an ANN system and varying 
constraints between neural units. Because ANN are trained rather than programmed, this 
leads to further refinement of the model being tested (Tu JV, 1996). Fahn S (1982) 
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purported that pathophyiological complications ofPD should be divided into 
phannacokinetic and pharmacodynamic mechanisms. 
Pharmacokinetic complications relate to problems with absorption and the 
metabolism of levodopa (Spencer SE and Wooten GF, 1984). For instance the use of 
continuous DA treatment by controlled release capsules helps reduce pharmacokinetic 
problems to advanced PO (Chase TN. et al., 1989). However, the pharmacokinetic 
aspects alone fail to explain the changes in effectiveness associated with drug therapies 
for PD (Fabbrini G. et al., 1987). 
Pharmacodynamic complications relate to the variables conditioning the response 
ofDA receptors that mediate motor behaviors (Spencer SE and Wooten GF, 1984). An 
ANN model ofPD was developed by Jamieson PW et al.(199l) that assessed the effects 
oflevodopa pharmacodynamics in PD" Jamieson PW et al. (1991) investigated the 
actions ofDA to determine: I) if DA alone was responsible for the LID produced during 
chronic treatment oflevodopa 2) how the degree ofDA depletion affects the reactivity in 
the striatum 3) if two phannacological mechanisms exist to explain the dyskinetic effects 
oflevodopa, and 4) ifboth 01 and 02 receptor types are necessary to produce these 
effects. They developed a number of related models to test the system using input units 
based on the two necessary components ofLID: degree ofDA depletion and pulsatile 
administration of levodopa (Jamieson PW et al., 1991 ). Motor behavior was the output 
(Jamieson PW et al., 1991). The models were tested using data from studies ofresponse 
fluctuations with levodopa treatment (Mouradian MM, 1988). The results from Jamieson 
PW et al. (1991) indicate that the effects of DA depletion and levodopa dose acting on 
DA receptors could not solely be responsible for the dyskinetic effects. The most 
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consistent data of the Jamieson study was the correlation of increased DA receptor 
stimulation to levodopa treatment with increased DA depletion (Jamieson PW et al., 
1991). These results are supported in many experiments that show a greater degree ofDA 
denervation correlates with a greater expression of LID (Bertorelli R and Consolo S 
1990). The results of the Jamieson study also implied that distinct mechanisms produce 
the antiparkinsonian effect of levodopa and LID (Jamieson PW et al., 1991 ). 
A more recent study by Wickens J and Kotter R (1998) used a computer model to 
explore the striatal mechanisms in PD. This study aimed to clarify some issues that were 
not addressed with earlier PD models (Wickens J and Kotter R, 1998). One such issue is 
the changes in patterns of neural firing in the basal ganglia that are likely to underlie the 
symptoms of PD (Wickens J and Kotter R, 1998). Much of their focus was on dendritic 
spines of striatal neurons, regarding them as isolated biological compartments (Wickens J 
and Kotter R, 1998). The use of dendritic spines in this manner allowed the researchers to 
study the postsynaptic interactions between glutamatergic and dopaminergic afferents in 
the striatum (Wickens J and Kotter R, 1998). They noted that following DA depletion, 
the morphology of striatal neurons is altered leading to a reduction in the length of 
individual spines and a decrease in the overall number of spines (Ingham CA et al., 
1993 ). They hypothesize the change in firing patterns in the striatum is one way to 
compensate for the morphological and physiological changes in the basal ganglia that 
occur after DA denervation (Wickens J and Kotter R, 1998). Their computer simulations 
predict that there is a limit to such compensatory mechanisms in the basal ganglia and 
indicate that the effect of levodopa may be to prolong existing bursts in firing patterns in 
striatal neurons but not to generate new burst (Wickens J and Kotter R, 1998). Therefore, 
49 
they propose the compensatory mechanisms following DA denervation fail to be 
effective when corticostriatal excitation drops below a critical level needed to increase 
firing rates in striatal neurons (Wickens J and Kotter R, 1998). This suggests that changes 
in firing patterns of striatal neurons induce changes in synaptic plasticity that may alter 
the expression in the striatum from LTD to LTP. This has been the case in previously 
studied animal models of continuous versus pulsatile levodopa administration where 
firing patterns determine whether or not LID developed. These changes in firing patterns 
could also correlate with LTD (no LID) and L TP (LID). 
A similar study was done by Terman D. et al. (2002), using a computational 
network model of activity patterns in the subthalamopallidal circuit of the basal ganglia. 
They were particularly interested in assessing the dynamic interaction between STN and 
GPe that lead to oscillatory activity patterns within this subthalamopallidal circuit 
(Terman D. et al., 2002). They predict that the STN and GPe neurons have traits similar 
to those of a central pattern generator and therefore may be able to self-sustain oscillatory 
activity. Terman D. et al (2002) followed STN and GPe activity over time in contrast to 
most basal ganglia models that are static. Simulations were run to investigate the design 
correlating the network with the associated synaptic conductances that may be 
modulating the activity of these networks over time (Terman D. et al., 2002). Terman's 
models found that this subthalamopallidal circuit is capable of producing both correlated 
rhythmic activity and irregular autonomous patterns of activity (Terman D. et al., 2002). 
Because neurons in both of these areas have similar membrane properties it was expected 
that they would be predisposed to rhythmic firing (Terman D. et al., 2002). Rhythmic 
firing refers to correlated patterns between STN and GPe occurring through an elevation 
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of striatal input coupled with a decrease of intrapallidal inhibition (Terman D. et al., 
2002). Understanding what causes the change in the circuitry following changes in 
striatal input could shed insight into what causes the striatal circuitry change following 
DA denervation. An increase in striatal input and weakened intrapallidal inhibition within 
the indirect pathway can change the pattern of the circuit from irregular to rhythmic 
(Terman D. et al., 2002). The investigators speculate this may be why oscillatory activity 
in the subthalamopallidal circuit arises after DA denervation in PD (Terman D. et al., 
2002). This is similar to the matrix circuitry involved in LID which creates an oscillation 
of physiological states of striatal neurons following levodopa treatment. This is another 
example of a subtle change in basal ganglia circuitry, in this case changes in firing 
patterns between GPe and STN, that has a strong influence on the activity of striatal 
neurons. 
It seem reasonable to suspect the changes in firing patterns that occur after DA 
denervation in the striatal neurons is due to the interaction of glutamate and ACh coupled 
with levodopa treatment. Pulsatile administration of levodopa activates the striosomal 
pathway and therefore produces new signaling patterns in the basal ganglia circuitry 
( Graybiel AM et al., 2000). Because the striatum is capable of producing LTD and LTP, 
an appropriate neural network model would need to be bimodal in order to account for 
the expression of these two synaptic plasticity mechanisms. 
A similar model was described in the hippocampus by Huerta and Lisman (1995) 
which described a bimodal heterosynaptic plasticity induced during cholinergic 
oscillation in vitro. The frequency of synaptic stimulation appears to determine whether 
CAl synapses express LTD or LTP (Huerta PT and Lisman JE, 1995). The investigators 
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found that cholinergic oscillatory bursts were responsible for inducing L TP or LTD in the 
CAl area ofthe hippocampus (Huerta PT and Lisman JE, 1995). The cholinergic system 
originating in the medial septum innervates the whole hippocampus and is known to 
enhance synaptic plasticity (Huerta PT and Lisman JE, 1995). Studies have shown that 
low doses of cholinergic agonists produce a slight enhancement of L TP in the 
hippocampus whereas high doses of cholinergic agonists produce a network oscillation 
(Burgard EC and Sarvey JM, 1990). Following DA denervation, there is an elevation of 
ACh in the striatum that may be responsible for L TP expression in the striatum in a 
manner similar to that observed in Huerta and Lisman's study. Huerta PT and Lisman 
JE( 1995) looked specifically at the type of synaptic plasticity produced during very brief 
bursts of stimulation in the hippocampus (4 shocks at lOO Hz) in vitro. Previous studies 
had suggested the frequency of synaptic stimulation determines whether LTD or L TP is 
produced (Artola A and Singer W, 1993; Teyler TJ et al., 1994). The results of Huerta PT 
and Lisman JE (1995) showed that during the cholinergic oscillations the timing of the 
stimulation relative to the oscillation phase predicted the type of synaptic plasticity, 
which determined whether LTD or L TP was expressed (Huerta PT and Lisman JE, 1995). 
For instance when excitatory postsynaptic potentials (EPSP) spikes were plotted over 
time they found L TP was expressed when these cholinergic oscillations were at the peak 
and LTD when they were at their trough (Huerta PT and Lisman JE, 1995). This suggests 
a correlation between excitatory stimulation and L TP and this excitation may be directly 
proportional to calcium influx. During the network oscillation, CAl neurons ofthe 
hippocampus display subthreshold and suprathreshold oscillations, with amplitudes of 5-
25 mV (Leung LS and Yim CY, 1986; MacVicar BA and Tse FW, 1989). Such 
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postsynaptic voltage fluctuations could influence plasticity by increasing stimulation 
intensity. The oscillating behavior itself is induced by cholinergic action and in its 
absence synaptic plasticity is greatly reduced (Huerta PT and Lisman JE, 1995). This 
suggests ACh plays a strong role in synaptic plasticity. In addition, cholinergic 
innervation is able to depolarize pyramidal neurons by blocking potassium channels that 
reduces calcium influx inhibition (Huerta PT and Lisman JE, 1995). Therefore, the study 
by Huerta PT and Lisman JE ( 1995) supports the idea that ACh intemeurons have a 
strong role in heterosynaptic plasticity in the hippocampus. It is reasonable to suggest that 
a similar mechanism may be taking place in the striatum since the anatomical 
arrangement that allows heterosynaptic plasticity in the striatum has the potential for 
bimodal synaptic modification: LTD and L TP. By designing a network that represents the 
neurotransmitters involved in striatal heterosynaptic plasticity that would produce L TO 
and inhibit LTP, a network model for controlling LID may lay the foundation for future 
experimental analysis. 
A bidirectional neural network was modeled by Wakuya Hand Zurada JM (2001) 
in tracking sun spot data. The beauty of this model is that it has the ability to portray two 
subnetworks performing two types of signal transfonnations bidirectionally. In this 
model it takes past information and compares it to new input infomution. For systems 
that rely on past information to predict future outcomes, this model is particularly useful 
(Figure 16 ). In addition, the subnetworks receive complementary signals through mutual 
connections (Wakuya Hand Zurada JM, 2001). 
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Figure 16 (modified from Wakuya Hand Zurada JM, 2001). Bidirectional ANN Model 
Based Upon Past and Present Values to Predict Future Values. Outline of the signal flow 
within the bidirectional computing structure. In this figure, the upper half deals with the 
fitture prediction task, a transformation from the present signal to the future signal. The 
lower half deals with the past prediction task, a transformation from the desired fi-tture 
signals to the present signal. These two transformations cooperate with each other 
through their mutual connections. 
Such a model seems appropriate for illustrating the heterosynaptic bimodal 
synaptic plasticity in the striatum. The bimodality illustrates the ability of the striatal 
medium spiny neurons to oscillate towards a depolarized or hyperpolarized state and 
depicts the synaptic plasticity correlated with these states. The depolarized state has been 
associated with L TP, a mechanism induced by DA administration following DA 
denervation (Calabresi P. et al., 1999). The optimal neural network design would then 
seem to be one that used DA agonist, glutamate antagonists and ACh antagonist as input 
components and trained the network by varying their concentrations and effects on 
synaptic plasticity based on one particular neurotransmitter (e.g. ACh, DA or glutamate), 
while assessing their collaborative effects. The goal would be to determine which 
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combinations produce the output (LTD) and which produce the output (L TP). An 
illustration of such an ANN of bimodal heterosynaptic plasticity in the striatum similar to 
the bidirectional model used by Wakuya H. and Zurada JM is depicted in Figure 17. 
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Figure 17: ANN Model of Bimodal Heterosvnaptic Mechanism in the Striatum. The upper 
half of the diagram shows chronic levodopa that leads to LTP and LID, the bottom half 
illustrates the hJpothesis that ACh and/or glutamate antagonists may inhibit LTPILID 
and produce LTD. The middle components, LTD and LTP, represent the fact these two 
states oF'>:vnaptic plasticity are flexible and exist in an extended continuum based upon 
the amount of calcium in the system. 
If the model predicts that activation of certain combinations of neurotransmitters 
produces LTD along with the simultaneous inhibition of L TP, it may be advantageous to 
further investigate the results by a laboratory experiment to verify the neural network 
model. Confirmation of this model may lay the groundwork for improved 
pharmacological intervention in the treatment of PD. [t has been observed that following 
DA denervation, changes in striatal levels of ACh and glutamate are observed. Both 
glutamate and ACh interact and are modulated by DA. Both LTD and L TP depend upon 
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DA and glutamate in the striatum. However, the role of ACh in producing either of these 
two long term mechanisms, L TP and L TO, has not been thoroughly addressed. These 
three neurotransmitters: DA, glutamate and ACh need to be assessed individually first, 
followed by the effects of their interaction to see how they might direct the 
heterosynaptic plasticity towards L TO or L TP. 
A similar design was modeled by Castellani GC et al. (200 1 ). Researchers looked 
at bidirectional synaptic plasticity in the mammalian cortex and its dependence on AMP A 
and NMDA receptors. Their model denoted the particular states of LTD and L TP as a 
function of calcium concentration (Castellani GC et al., 2001). Their model claims that 
by knowing the local postsynaptic concentration of intracellular calcium one may deduce 
the status ofNMDA receptor subunit phosphorylation and thus synaptic efficacy. They 
conclude that changes in the number and/or subunit composition ofNMDA glutamate 
receptors in the postsynaptic membrane determine the calcium concentration and 
therefore LTD or LTP (Castellani GC et al., 2001). Phosphorylation sites on NMDA and 
AMP A receptors can therefore serve as a predictor of a change in the direction of 
synaptic strengthening or weakening (Figure 18) (Castellani GC et al., 2001 ). 
Clearly ANN have a useful place in scientific research. As mentioned ANN can 
be designed with less formal training than in standard statistical modeling and offer 
superior assessment of nonlinear relationships. ANN are limited in their 
oversimplification of biological processes but remain a good starting point for assessing 
variables and laying the foundation for laboratory experimentation. A few negative facts 
to note about ANN are their limitations in validating causal relationships (Tu JV, 1996). 
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Figure 18: (modified from Castellani GC eta!., 200 I) Direction of Plasticity: LTD or 
LTP Depends Upon Phosphorylation Sites. Phosphorylation sites influence the amount of 
calcium present at the AivtPA receptors (from Castellani et a/.,2001). A model ofGlu Rl 
phosphorylation/dephosphorylation at two sites. The model assumes tlvo specific kinases 
(kinase!, kinase2) and two opposing specific phosphatases {phosphatase] 
,plwsphatase2). Presumably, high frequency stimulation preferentially stimulates the 
activit}' of protein kinases resulting in GluRI phosphorylation. Low frequency stimulation 
preferentially stimulates the activity of protein phosphatases resulting in GluR I 
dephosphotylation 
In other words, it is often difficult to be certain of the deeper relationships that may be 
hidden in the data or conversely, relationships may appear to exist on the surface but may 
just be false positives. In this respect, logistical models from standard statistics are far 
better at and often focus on inferring causal relationships (Tu JV, 1996). In logistic 
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regression, variables may be determined which are the strongest predictors of outcomes 
based on odds ratio and beta-coefficients (Tu JV, 1996). In addition, in a stepwise 
manner, independent variables may be eliminated if they are not correlated to a particular 
outcome (Tu JV, 1996). In an ANN, the training data are fed into the system and the 
network trains itselfby finding the input variables that produces a particular outcome (Tu 
JV, 1996). In this arrangement, insignificant predictor variables may not be recognized 
since no reliable criteria exist for interpreting weights in a connection weight matrix (Tu 
JV, 1996). The intent ofthe ANN for the LID model may be at a significant disadvantage 
because relationships between neurotransmitters and their respective agonists and 
antagonists may show a correlation with L TP without being mechanistically linked. 
However, these relationships could be verified through laboratory experimentation. 
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CHAPTER6 
FACTORS IN ASSESSING STRIATAL HETEROSYNAPTIC LTP PLASTICITY 
DA and ACh 
Although many studies have been conducted that examines the relationship 
between DA and glutamate and other studies have probed the relationship between DA 
and ACh, little research exists that has combined the interaction of all three of these 
neurochemicals and their effects on LID. In recent years, researchers have verified the 
significance of both pulsatile administration of DA in the DA denervated system and an 
increase in glutamate in producing striatal L TP over LTD ( Calabresi P. et al., 1997). 
However, the role of ACh in striatal LTD and L TP have not been clearly defined. It is 
thought that DA, glutamate and ACh interactions may produce LID as a possible result of 
inducing L TP in the striatum. By designing a neural network that will combine aspects of 
research data including: levodopa levels, ACh antagonist levels, glutamate antagonist 
levels, and their effects on inhibiting L TP, possible insight into controlling striatal LID 
may result. Such correlations would allow laboratory experimentations to further 
investigate this hypothesis. In designing this model, it may be advantageous to review 
what is known about each independent variable first, then decide on the best design to 
assess the variable DA-ACh-glutamate interactions. 
Initial observations ofthe interactions between DA and ACh in the 
extrapyramidal system were based upon clinical investigations ofPD patients in the early 
1960s (Lehman 1 and Langer SZ, 1983). Muscarinic receptor antagonists that decrease 
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cholinergic function, relieve PD symptoms in a manner similar to DA agonists (Lehman J 
and Langer SZ, 1983). Therefore it was proposed by researchers that the endogenous 
neurotransmitters, DA and ACh, had opposite functions in the extrapyramidal system 
(Lehman J and Langer SZ, 1983 ). It was soon postulated that under normal conditions, 
ACh and DA are in a state ofbalance (Barbeau A, 1962). 
TheDA and ACh interaction is also observed in biochemical studies of 
neurotransmitter turnover. Administering DA receptor agonists produces a decrease in 
ACh turnover in the striatum (Lehman J and Langer SZ, 1983). In response to DA 
receptor agonist, apomorphine, there is a decrease in ACh release and turnover in the 
intact system. The first model to explain the DA and ACh interactions emerged in the 
1970s which claimed DA terminals in the striatum form inhibitory connections on the 
dendrites of the striatal cholinergic interneurons. This allowed DA receptor stimulation to 
inhibit the activity of cholinergic interneurons by acting as a link between DA terminals 
and other interneurons or to efferent neurons in the striatum (Lehman J and Langer SZ, 
1983). This would allow ACh interneurons to act as a trans-synaptic "second-messenger" 
of DA receptor stimulation. However, anatomical and pharmacological data conflicted 
with the idea that ACh dendrites were the exclusive or even most abundant postsynaptic 
target ofDA terminals (Lehman J and Langer SZ, 1983). Thus, although a relationship 
between DA and ACh exists, the details of this interaction appear to be more elusive. 
Huerta PT and Lisman JE (1993) found cholinergic agonists depolarized striatal 
neurons by blocking potassium channels. The depolarization of striatal neurons is also a 
factor in eliciting striatal L TP. As noted earlier, striatal neurons are usually at a low level 
of excitation and express LTD due to the numerous open potassium channels that 
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counteract the influx of calcium. Therefore blocking ACh receptors may be one factor 
affecting striatal L TP formation following DA denervation and levodopa treatment 
systems. Other evidence suggests muscarinic receptor activation has a role in stabilizing 
striatal transition states (Suzuki T. et al., 1998). While the majority of cholinergic 
intemeurons are located in the matrix of the striatum, their neurites extend into the 
striosomes and therefore could serve as a link between these two striatal compartments 
(Blanchet F. et al., 1997). The density of cholinergic intemeurons is about two fold 
higher along the matrix/striosome border compared to regions outside of this border 
(Blanchet et al., 1997). Thus, ACh seems to be ideally positioned to serve in the 
heterosynaptic plasticity between the striosomes and the matrix. 
DA and Glutamate 
Studies have shown both DA and glutamate are necessary elements for LTD and 
LTP expression (Calabresi P. et al., 1997). DA denervation is accompanied by an 
increase in glutamate that affects the striatal physiological states of neurons. Following 
chronic levodopa treatment LTP is expressed over LTD. NMDA and AMPA receptors 
are located on ACh intemeurons and medium spiny neurons in the matrix of the striatum 
(Calabresi P. et al., 1999). Scientists have found a relationship between NMDA receptor 
activation on medium spiny neurons and L TP expression in these same neurons in DA 
denervated systems treated with levodopa (Calabresi P. et al., 1999). Following DA 
denervation, there is an increase in striatal levels of ACh and glutamate (Starr MS, 1995). 
Such excitatory chemical input could alter physiological striatal states. Interestingly, 
61 
Gubellini P. et al. (1997) found that endogenously produced ACh enhanced NMDA 
responses, which increased protein kinase C (PKC) activation in medium spiny neurons. 
This suggests a possible role of ACh inducing a long lasting elevation of corticostriatal 
glutamatergic transmission (Gubellini P. et al., 1997). Studies have shown that the 
increase in ACh may allow for more binding of glutamate at NMDA receptors (Gubellini 
P. et al., 1997). They also documented that glutamate binding to NMDA receptors 
stimulates the release of ACh in striatal compartments indicating that there seems to be 
some role of positive feedback and/or coupling between ACh and glutamate following 
DA denervation (Blanchet F. et al., 1997). 
Bimodal regulation of synaptic strength has been hypothesized to depend on 
changes in the number and/or the composition ofNMDA and AMPA glutamate receptor 
subunits. Glutamate receptors' function is regulated by their subunit composition on 
individual receptors and/or the phosphorylation/dephosphorylation state of individual 
subunits. Therefore, knowledge ofthe phosphorylation states of AMPA subunits and 
NMDA subunits may be a strong predictor of the modality change (increase/decrease) of 
calcium influx and therefore whether LTD or L TP is induced. 
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CHAPTER 7 
CONCLUDING REMARKS 
Among the flaws in the current basal ganglia model are that it does not take into 
account the anatomical and functional differences between the neurons in the matrix and 
in the striosomes of the striatum nor the possibility of their influence upon one another. 
Although most basal ganglia research has independently focused on their control of 
movement and their role in memory and learning, very few researchers have drawn 
correlations between these two lines of study. The possibility that the striosomal pathway 
may influence the direct and indirect striatal pathways of the matrix can be assessed on 
two levels. First, the striosomal pathway projects to the SNc that gives rise to the 
nigrostriatal pathway (Starr MS, 1995). Therefore, a cooperative system may exist in the 
striatum not simply between the direct and indirect pathways, but between the striosomal 
pathway and the matrix as well. It is possible that the striosomal pathway may serve to 
regulate or evaluate incoming signals to the nigrostriatal pathway through a 
heterosynaptic mechanism and once the neurotransmitter systems (i.e. DA and glutamate) 
are disrupted in PD, the control of input signals into the striatum is reduced. Secondly, 
lining the border between the striosomes and matrix are ACh intemeurons (Pollack AE, 
2001; Starr MS, 1995). These ACh intemeurons are in the position to relay information 
from the striosomal pathway to the direct and indirect pathways of the matrix through a 
heterosynaptic mechanism. The information communicated from the striosomes to the 
matrix may elicit protein changes in the medium spiny neurons of the cells ofthe striatal 
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matrix. These protein changes may contribute to NMDA receptor activation and 
increased calcium influx. Therefore a bimodality in the heterosynaptic mechanism may 
explain the differences in responses to continuous versus intermittent levodopa 
administration eliciting either LTD or L TP in the striatum. 
A disruption in the balance between DA and glutamate interaction in the striatum 
develops following DA denervation and subsequent levodopa treatment. It is not known 
to what extent ACh functions to modulate the concentrations ofDA, glutamate and 
calcium in the striatum, but clearly ACh plays a role since NMDA and AMPA receptors 
are found on ACh intemeurons in the striatum (Calabresi P. et al., 1995). In addition, 
following DA denervation, striatal neurons, usually in a hyperpolarized state, transition 
into an oscillatory state, changing from a hyperpolarized to a depolarized state (Calabresi 
P. et al., 2000). This oscillatory behavior is not caused by intrinsic membrane properties, 
but is the result ofDA denervation and the release of glutamate from cortical neurons 
( Calabresi P. et al., 2000). Just as oscillatory neuronal states are not typical for the intact 
and normal functioning striatum, L TP is not typically the mechanism expressed in the 
striatum; under nom1al circumstances, the striatum typically expresses LTD and 
following DA denervation and levodopa treatment, L TP is produced in the striatum 
(Calabresi P. et al., 2000). 
In many regions of the brain, including the cortex, the magnitude and sign of 
activity dependent changes in synaptic strength depend on the presynaptic frequency of 
firing as well as the history of activity at those synapses (Castellani GC et al., 2001 ). By 
comparing different dosages oflevodopa, ACh and glutamate antagonists and by 
assessing the relationship ofthese three neurotransmitters in a bimodal neural network 
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system, manipulation of LTD over LTP may be achieved. In the model designed for 
assessing the interactions among ACh, glutamate and DA, each ofthese 
neurotransmitters will be used as an input into the system (Figure 19). Various doses of 
levodopa, ACh and glutamate antagonists for each of these transmitters will be given to 
act on each variable independently as well as simultaneously. The system will be trained 
to produce the output LTD and inhibit the output LTP formation by adjustment ofthe 
input variables ACh, glutamate and DA. 
Necessary elements for building a neural network for therapeutic doing of PD 
would include a collection of data of the variables described above. The immediate object 
is to decrease the excitability and thus, the depolarized state of striatal neurons that will 
further block excitation via NMDA receptor stimulation, thereby, preventing LTP. It is 
not known which variables: levodopa levels, ACh antagonist levels or glutamate 
antagonist levels or if a combination of variables will be the most successful in 
preventing LTP and producing LTD in the neural network model. . The long-term 
mechanisms (i.e. LTD and LTP) can be directed either way depending on the variables 
and their nonlinear relationship. An expanded version of a bidirectional/bimodal model is 
found in Zurada JM ( 1992) (Figure 20). 
A condensed and simplified version of this bi-directional/bimodal model is 
illustrated (Figure 21 ). The fundamental structures of Figure 20 and Figure 21 are based 
upon Zurada's (1992) bidirectional/bimodal associative memory ANN that uses 
stimulus/response association to produce output. Details are found in the Appendix. 
Current and past research has studied the independent effects of anticholinergics 
and glutamate antagonists on rotational behavior in animal experiments as well as clinical 
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treatments to decrease LID in PD patients. The reasons why these treatments are effective 
in decreasing LID have not been understood. Ifthese variables: levodopa levels, ACh 
antagonist levels and glutamate antagonist levels either acting independently or 
interacting together control calcium influx in the striatum, this would prevent L TP. No 
such experiments have been found in recent literature. However, anticholinergics are 
known to have very severe side effects on memory. Chemical agents that alter 
phosphorylation of AMP A subunits may be one alternative to anticholinergics and 
general NMDA antagonist since increased phosphorylation of AMPA receptors has a 
direct inverse relationship with calcium influx (Castellani GC et al., 2001). Thus, at 
higher levels of AMP A subunit phosphorylation there is a lowering of intracellular 
calcium concentration and less chance for LTP to develop (Castellani GC et al., 2001 ). 
Although the ANN presented in this thesis does not focus on this issue, potential 
experiments may want to address this issue. 
Many computational models have been designed to study the dynamics of PD. 
Such idealized models form a solid foundation for laboratory experimentation. Thus, the 
ultimate goal of designing an ANN model to produce LTD and inhibit LTP would be to 
test therapeutic dosing regiments in a laboratory environment in hopes of offering novel 
treatments for PD patients. Since independent variables that will produce the most 
effective LTP suppression have not been assessed, the computational model will be an 
efficient tool in unveiling these variables. 
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Figure 19: Inputs and Nonlinear Assessment to the LTD Ouput: Interactions amongst the 
inputs: levodopa, ACh antagonist and glutamate antagonist combine to yield LTD. This is 
accomplished by minimizing calcium levels and thereby suppressing LTP formation in 
the striatum. The nonlinear interactions take place in the hidden layer and the 
combinations that yield LTD will be produced as the output. 
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Layer A Layer B 
Figure 20: (modified from Zurada, 1992). Expanded Bidirectional ANN Model (from 
Zurada, 1992). A bidirectional neural network uses the forward and backward 
information flow to produce an associative search for stored stimulus-response 
association 
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Figure 21: Bimodal ANN Model ofLTD-LTP in the Striatum. The appropriate 
combination oflevodopa, ACh antagonist and glutamate antagonist will produce either 
L TP or LTD in the striatum. An output that generates an elevation in calcium will 
produce L TP and an output that generates a relative inhibition of calcium will produce 
LTD. 
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To date, treatment for PD with levodopa has retained a compromised clinical 
benefit. The worst and most disabling side effect consists of LID that almost always 
appears after chronic levodopa treatments. If the hypothesis that LID are a manifestation 
of L TP in the striatum is correct, then new avenues of treatment for PD will follow. 
Alternative therapies will be explored that offer less side effects compared to the current 
standard treatments that produce LID and compromise PD patients' standard of living 
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APPENDIX 
Zurada's (1992) bidirectional/bimodal associative memory ANN that uses 
stimulus/response association to produce output. 
eq. 1 
These sets are association pairs that are stored in the memory model. If the 
memory neurons are activated, the network dynamics correlates two layers of interaction. 
Refer once again to Figure 16. Assume an initializing vector b at the input to the layer A 
of neurons. In the assumption, layer A L TP. This input will be processed through the 
hidden layer as follows: 
a' f[Wb] 
eq.2 
This equation is a nonlinear operator. It involves matrix multiplication. If layer A 
= LTP, layer B =LTD 
a~ = sgn ( ~ W··b) fori = 1, 2, ... , n I ."-' I) } ' yl 
eq.3 
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Vector a' feeds the layer B, LTD, of neurons. If the transposed matrix is used, W' 
of layer B, we find: 
eq.4 
Again, matrix multiplication processes the information: 
bj = sgn (.f wua;), for j = 1, 2, ... , m 
i=l 
eq. 5 
This sequence will be repeated to compute a', b', and so on ... The process 
continues as information is received. Once data is no longer being updated, the a & b 
functions will stop. It is a recursive update mechanism consisting ofthe following steps: 
First Forward Pass: 
First Backward Pass: 
Second Forward Pass: 
k/2'th Backward Pass: 
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a 1 = f[Wb0] 
b2 = f[Wra 1] 
a3 = f[Wb2] 
The back and forth nature of the flow, aims to equilibrate in one of the fixed pairs from 
eq. 1. 
It should be noted, in this particular memory model, that an assumption is made 
that no state changes are occurring in layers A and B at the same time. Data must flow in 
a circular fashion. In other words, one cannot simultaneously be at output A and output 
B. This makes sense in the L TP/L TD model. The direction of flow in the L TP/L TD 
depends on the level of calcium, the type of glutamate receptor activated and the DA 
pulsatile activation encountered. 
Once data is processed it is coded into the bidirectional/bimodal associative 
memory usually by the outer product rule, or simply by adding p cross-correlation 
matrices (Zurada, 1992). The weight matrix formula is: 
W = f a<i)b(i)r 
i=l eq.6 
[n eq. 6, a(i) and b(i) are members of the ith pair and are equivalent to the 
Hebbian learning rule which yields the following weight values: 
p 
W·· = ~ a~m)b~m) 
lJ £... l J 
m=l eq. 7 
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If a stored pattern, a/\(m/\t) is presented to this memory, the retrieval process 
follows from eq.5: 
eq. 8 
This further reduces to: 
b = r [nb(m') + f b(m)a(m)ta(m')] 
m'i=m' 
eq.9 
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